A new generation of COVID-19 vaccines that can be inhaled or sprayed up the nose—instead of taken by injection—will begin rolling out in Asia, though just how effective they are remains to be seen. Regulators in China and India...
Article by Lalita Panicker, Consulting Editor, Views and Editor, Insight, Hindustan Times, New Delhi
A large-scale efficacy trial of a promising tuberculosis (TB) vaccine will soon launch with substantial backing from two major philanthropies. The vaccine, dubbed M72, has so...
